UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug development for CNS disorders: strategies for balancing risk and reducing attrition

Nature reviews. Drug discovery, 2007-07, Vol.6 (7), p.521-532

2007

Volltextzugriff (PDF)

Drug Development for Rare Mitochondrial Disorders

Neurotherapeutics, 2013-04, Vol.10 (2), p.286-306

Hurko, Orest

2013

Volltextzugriff (PDF)

The Uses of Biomarkers in Drug Development

Annals of the New York Academy of Sciences, 2009-10, Vol.1180 (1), p.1-10

Hurko, Orest

2009

Volltextzugriff (PDF)

Target-based drug discovery, genetic diseases, and biologics

Neurochemistry international, 2012-11, Vol.61 (6), p.892-898

Hurko, Orest

2012

Volltextzugriff (PDF)

Drug Development for Rare Mitochondrial Disorders

Neurotherapeutics, 2013-04, Vol.10 (2), p.286-306

Hurko, Orest

2013

Volltextzugriff (PDF)

Target-based drug discovery, genetic diseases, and biologies

Neurochemistry international, 2012, Vol.61 (6), p.892-898

HURKO, Orest

2012

Volltextzugriff (PDF)

Drug development for CNS disorders: strategies for balancing risk and reducing attrition

Nature reviews. Drug discovery, 2007-07, Vol.6 (7), p.521-532

2007

Volltextzugriff (PDF)

Future drug discovery and development

Molecular genetics and metabolism, 2010, Vol.100 Suppl 1, p.S92-S96

Hurko, Orest

2010

Volltextzugriff (PDF)

Respiration and Growth Defects in Transmitochondrial Cell Lines Carrying the 11778 Mutation Associated with Leber's Hereditary Optic Neuropathy

The Journal of biological chemistry, 1996-05, Vol.271 (22), p.13155-13161

1996

Volltextzugriff (PDF)

Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease

Parkinsonism & related disorders, 2023-03, Vol.108, p.105281-105281, Article 105281

2023

Volltextzugriff (PDF)

Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch

Stroke (1970), 2009-10, Vol.40 (10), p.e558

2009

Volltextzugriff (PDF)

Schizophrenia-Related Neural and Behavioral Phenotypes in Transgenic Mice Expressing Truncated Disc1

The Journal of neuroscience, 2008-10, Vol.28 (43), p.10893-10904

2008

Volltextzugriff (PDF)

Ablation of the Locus Coeruleus Increases Oxidative Stress in Tg-2576 Transgenic but Not Wild-Type Mice

International journal of alzheimer's disease, 2010, Vol.2010 (2010), p.1-13

2010

Volltextzugriff (PDF)

Translational Research in Central Nervous System Drug Discovery

NeuroRx, 2005-10, Vol.2 (4), p.671-682

2005

Volltextzugriff (PDF)

Valuation of biomarkers

Nature reviews. Drug discovery, 2011-04, Vol.10 (4), p.253-254

2011

Volltextzugriff (PDF)

Importance and hurdles to drug discovery for neurological disease

Annals of neurology, 2013-09, Vol.74 (3), p.441-446

2013

Volltextzugriff (PDF)

The impact of preclinical drug safety on R&D productivity: 23 - 25 May 2006, Philadelphian Convention Centre, USA

Expert opinion on drug discovery, 2006-09, Vol.1 (4), p.369-372

Hurko, Orest

2006

Volltextzugriff (PDF)

The Skin and Neurologic Disease

Aminoff's Neurology and General Medicine, 2021, p.343-369

Sixth Edition, 2021

Volltextzugriff (PDF)

The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors

NeuroImage (Orlando, Fla.), 2012-02, Vol.59 (4), p.4196-4200

2012

Volltextzugriff (PDF)

Family study and segregation analysis of Tourette syndrome : Evidence for a mixed model of inheritance

American journal of human genetics, 1996-09, Vol.59 (3), p.684-693

1996

Volltextzugriff (PDF)

Marked Replicative Advantage of Human mtDNA Carrying a Point Mutation that Causes the MELAS Encephalomyopathy

Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11164-11168

1992

Volltextzugriff (PDF)

Multimodal magnetic resonance imaging for assessing evolution of ischemic penumbra: a key translational medicine strategy to manage the risk of developing novel therapies for acute ischemic stroke

Journal of cerebral blood flow and metabolism, 2009-01, Vol.29 (1), p.217-219

2009

Volltextzugriff (PDF)

Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development

European neuropsychopharmacology, 2001-12, Vol.11 (6), p.491-499

Hurko, Orest

2001

Volltextzugriff (PDF)

Disorders of binocular control of eye movements in patients with cerebellar dysfunction

Brain (London, England : 1878), 1996-12, Vol.119 (6), p.1933-1950

1996

Volltextzugriff (PDF)

Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk

Drug development research, 2009-03, Vol.70 (2), p.60-69

2009

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(75)
Buchkapitel
(3)

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug development for CNS disorders: strategies for balancing risk and reducing attrition

Drug Development for Rare Mitochondrial Disorders

The Uses of Biomarkers in Drug Development

Target-based drug discovery, genetic diseases, and biologics

Drug Development for Rare Mitochondrial Disorders

Target-based drug discovery, genetic diseases, and biologies

Drug development for CNS disorders: strategies for balancing risk and reducing attrition

Future drug discovery and development

Respiration and Growth Defects in Transmitochondrial Cell Lines Carrying the 11778 Mutation Associated with Leber's Hereditary Optic Neuropathy

Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson's disease

Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch

Schizophrenia-Related Neural and Behavioral Phenotypes in Transgenic Mice Expressing Truncated Disc1

Ablation of the Locus Coeruleus Increases Oxidative Stress in Tg-2576 Transgenic but Not Wild-Type Mice

Translational Research in Central Nervous System Drug Discovery

Valuation of biomarkers

Importance and hurdles to drug discovery for neurological disease

The impact of preclinical drug safety on R&D productivity: 23 - 25 May 2006, Philadelphian Convention Centre, USA

The Skin and Neurologic Disease

The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors

Family study and segregation analysis of Tourette syndrome : Evidence for a mixed model of inheritance

Marked Replicative Advantage of Human mtDNA Carrying a Point Mutation that Causes the MELAS Encephalomyopathy

Multimodal magnetic resonance imaging for assessing evolution of ischemic penumbra: a key translational medicine strategy to manage the risk of developing novel therapies for acute ischemic stroke

Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development

Disorders of binocular control of eye movements in patients with cerebellar dysfunction

Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk

Suchergebnisse filtern